- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by Bristol Myers Squibb Pharmaceuticals Limited
Total 2651 results
-
Bristol-Myers SquibbSolvay PharmaceuticalsTerminated
-
Solvay PharmaceuticalsBristol-Myers SquibbWithdrawnObesity and Type 2 Diabetes
-
Regeneron PharmaceuticalsBristol-Myers SquibbCompletedMelanoma | Metastatic Melanoma | Unresectable Melanoma | Advanced MelanomaUnited States
-
Regeneron PharmaceuticalsBristol-Myers SquibbActive, not recruitingMelanoma | Metastatic Melanoma | Unresectable Melanoma | Advanced MelanomaUnited States
-
Bristol-Myers SquibbNot yet recruitingLactating Women | Breastfed Infants
-
Bristol-Myers SquibbRecruiting
-
Bristol-Myers SquibbNot yet recruitingObstructive Hypertrophic CardiomyopathyKorea, Republic of
-
Bristol-Myers SquibbRecruitingMelanomaSpain, United States, Italy, Chile, Greece, Argentina
-
Bristol-Myers SquibbNot yet recruiting
-
Bristol-Myers SquibbRecruitingHealthy ParticipantsUnited Kingdom
-
Bristol-Myers SquibbNot yet recruitingMyelodysplastic Syndrome | Beta ThalassemiaKorea, Republic of
-
Bristol-Myers SquibbRecruitingRelapsed or Refractory T-cell LymphomasJapan
-
Bristol-Myers SquibbRecruitingHealthy Male VolunteersUnited States
-
Bristol-Myers SquibbRecruitingHealthy ParticipantsUnited States
-
Bristol-Myers SquibbRecruitingHealthy VolunteersUnited Kingdom
-
Bristol-Myers SquibbRecruitingMultiple MyelomaCanada, Taiwan, United States, Australia, Denmark, China, Korea, Republic of, Israel, Spain, France, Germany, Czechia, Austria, Sweden, United Kingdom, Greece, Japan, Italy, Finland, Argentina, Belgium, Brazil, Chile, Colombia, Hong Kong, Hungar... and more
-
Bristol-Myers SquibbRecruitingRelapsing-remitting Multiple Sclerosis (RRMS)Spain
-
Bristol-Myers SquibbRecruiting
-
Bristol-Myers SquibbRecruitingPsoriasisUnited States, Canada, Japan, Australia, Czechia, France, Poland, Spain, United Kingdom
-
Bristol-Myers SquibbRecruitingPsoriasisUnited States, Puerto Rico
-
Bristol-Myers SquibbRecruiting
-
Bristol-Myers SquibbRecruitingSystemic Lupus ErythematosusUnited States, Australia, Taiwan, Japan, Spain, Poland, Greece, Hungary, Puerto Rico, Mexico, Argentina, United Kingdom, Brazil, Chile, Peru, Turkey, Czechia, Bulgaria, Singapore, Portugal, India, Thailand
-
Bristol-Myers SquibbRecruitingSystemic Lupus ErythematosusUnited States, Brazil, China, Germany, Italy, France, Mexico, Poland, Puerto Rico, Argentina, Canada, Colombia, Hong Kong, Peru, Romania, Portugal, Turkey, Ireland, Korea, Republic of, India, Lithuania, Bulgaria, Slovakia
-
Bristol-Myers SquibbRecruitingObstructive Hypertrophic CardiomyopathyUnited States, Puerto Rico
-
Bristol-Myers SquibbRecruitingCrohn DiseaseUnited States, Belgium, Hungary, France, Canada, Spain, Australia, Germany, Poland, United Kingdom
-
Bristol-Myers SquibbRecruiting
-
Bristol-Myers SquibbRecruitingMultiple MyelomaNorway, United States, Spain, United Kingdom, Canada
-
Bristol-Myers SquibbRecruitingLymphoma, Non-Hodgkin | Hodgkin DiseaseUnited States, France, Netherlands, Australia, United Kingdom, Italy, Spain, Germany
-
Bristol-Myers SquibbRecruitingNon-Valvular Atrial Fibrillation (NVAF)Italy
-
Bristol-Myers SquibbRecruiting
-
Bristol-Myers SquibbRecruitingColitis, UlcerativeUnited States, Belgium, Germany, France, Russian Federation, Spain, Poland, Japan, Australia, Canada, Israel, United Kingdom
-
Bristol-Myers SquibbRecruitingSystemic Lupus ErythematosusUnited States, Argentina, Australia, Brazil, Chile, Colombia, Germany, Ireland, Japan, Mexico, Poland, Puerto Rico, Romania, Spain, Taiwan, China, France, United Kingdom, India
-
Bristol-Myers SquibbRecruitingRenal Allograft RecipientsFrance, United States, Belgium, Germany, Spain, United Kingdom, Italy, Netherlands
-
Bristol-Myers SquibbRecruitingLupus Erythematosus, Discoid | Lupus Erythematosus, Subacute CutaneousUnited States, Australia, Germany, Mexico, Russian Federation, Argentina, Poland, Taiwan, France
-
Bristol-Myers SquibbRecruitingExtensive-stage Small Cell Lung CancerUnited States, Belgium, Netherlands, Australia, Greece, Italy, Canada, Japan, Poland, Romania, Spain
-
Bristol-Myers SquibbCompletedSmall Cell Lung CancerUnited States, Belgium, Canada, Puerto Rico, Australia, Korea, Republic of, Netherlands
-
Bristol-Myers SquibbCompleted
-
Bristol-Myers SquibbActive, not recruitingPsoriatic ArthritisUnited States, Australia, Belgium, Spain, Argentina, China, Canada, Colombia, Czechia, Germany, Hungary, Italy, Japan, Mexico, Poland, Russian Federation, Taiwan, United Kingdom
-
Bristol-Myers SquibbTerminatedNonalcoholic Steatohepatitis (NASH)United States, Germany, Taiwan, United Kingdom, Spain, Argentina, Brazil, France, Israel, Italy, Japan, Korea, Republic of, Belgium, Canada, Puerto Rico, Switzerland
-
Bristol-Myers SquibbActive, not recruitingA Study of BMS-986253 in Combination With Nivolumab or Nivolumab Plus Ipilimumab in Advanced CancersMelanoma | CancerUnited States, Poland, Italy, Belgium, France, Australia, Canada, Germany, Spain, Sweden, Switzerland, United Kingdom
-
Bristol-Myers SquibbActive, not recruitingAdvanced Solid TumorCanada, United States, Mexico
-
Bristol-Myers SquibbCompletedHepatic ImpairmentUnited States
-
Bristol-Myers SquibbActive, not recruitingHealthy ParticipantsGermany
-
Bristol-Myers SquibbCompletedHypertrophic CardiomyopathyUnited States
-
Bristol-Myers SquibbTerminatedCrohn's Disease | Granulomatous Colitis | Crohn's Enteritis | Granulomatous EnteritisCanada, Germany, Taiwan, United States, Spain, Australia, Poland, Russian Federation, Japan, Korea, Republic of, Romania, Italy, United Kingdom, Belgium, Brazil, China, Czechia, France, Hungary, Ireland, Israel, Mexico, Netherlands, P... and more
-
Bristol-Myers SquibbCompleted
-
Bristol-Myers SquibbCompleted
-
Bristol-Myers SquibbActive, not recruitingRenal Cell CarcinomaFrance, Spain, Chile, United States, Argentina, Austria, Czechia, Greece, Italy, Mexico, Poland, Portugal, Romania, Russian Federation
-
Bristol-Myers SquibbCompleted
-
Bristol-Myers SquibbTerminatedCancer, HepatocellularChina, United States, Germany, Australia, Italy, Austria, Belgium, Czechia, France, Hong Kong, Japan, Korea, Republic of, Poland, Puerto Rico, Russian Federation, Singapore, Spain, Taiwan, Canada